Date | Compound | Laboratory | Indication | Type of Information |
---|---|---|---|---|
2012-04-26 | recombinant human methionine proinsulin | ProRetina Therapeutics (Spain) | retinitis pigmentosa |
Granting of the orphan status in the EU |
2016-01-04 | vosaroxin | Sunesis Europe Ltd (UK) | acute myeloid leukaemia |
Submission of a Market Application in the EU |
2012-03-26 | Yttrium (90Y)-DTPA-radiolabelled chimeric monoclonal antibody against frizzled homologue 10 | OncoTherapy Science France (OTS-France) (France) | soft tissue sarcoma | |
2012-04-04 | LMS-611 (multilamellar microvesicle comprising phosphatidylcholine, sphingomyelin, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol and cholesterol) | Lamellar Biomedical (UK) | cystic fibrosis | |
2016-04-26 | colorectal cancer blood test | Epigenomics (Germany-USA) | colorectal cancer |
Product launch |
2014-12-19 | beclomethasone dipropionate | Teva Pharmaceutical (Israel) | seasonal nasal and year-round nasal allergy symptoms |
Granting of a Market Authorisation in the US |
2012-03-26 | vorinostat | Merck&Co (USA) | multiple myeloma | |
2012-03-26 | synthetic double-stranded siRNA oligonucleotide directed against transthyretin mRNA | Voisin Consulting (France) | familial amyloid polyneuropathy | Granting of the orphan status in the EU |
2012-03-26 | recombinant thymidine phosphorylase encapsulated in autologous erythrocytes | St George\'s University of London (UK) | mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) due to thymidine phosphorylase deficiency | |
2012-03-26 | R-baclofen | Lakeside Regulatory Consulting Services Ltd (UK) | fragile X syndrome | |
2012-03-26 | ombrabulin | Sanofi (France) | soft tissue sarcoma |
Granting of the orphan status in the EU |
2012-03-26 | human anthrax monoclonal antibody | Emergent Sales and Marketing Germany GmbH (Germany) | inhalation anthrax disease | |
2018-01-08 | letermovir | AiCuris (Germany) Merck & Co (USA) |
|
Granting of a Market Authorisation in the EU |
2012-03-26 | glufosfamide | Theradex (Europe) Ltd (UK) | pancreatic cancer | |
2012-03-26 | darinaparsin | Ziopharm Oncology (USA) | peripheral T-cell lymphoma (nodal, other extranodal and leukaemic/disseminated) | |
2012-03-30 | [N-((2S,3R,3aS,3\R,4a\R,6S,6a\R,6b\S,7aR,12a\S,12b\S,Z)-3,6,11\,12b\-tetramethyl 2\,3a,3\,4,4\,4a\,5,5\,6,6\,6a\,6b\,7,7a,7\,8\,10\,12\,12a\,12b\-icosahydro-1\H,3Hspiro[furo[3,2-b]pyridine-2,9\ naphtho[2,1-a]azulene]-3\-yl)methanesulfonamide hydrochloride] | Voisin Consulting (France) | chondrosarcoma | |
2012-04-06 | lisuride hydrogenmaleate | Sinoxa Pharma (Germany) | pulmonary arterial hypertension (PAH) chronic thromboembolic pulmonary hypertension |
|
2012-03-30 | 9-cis-Retinyl acetate | ORS Oxford (UK) | Leber's congenital amaurosis | Granting of the orphan status in the EU |
2012-03-30 | 9-cis-Retinyl acetate | ORS Oxford (UK) | retinitis pigmentosa |
Granting of a patent |
2018-09-05 | gene therapy based on E2F4DN | Tetraneuron (Spain) | Alzheimer's disease | Granting of a patent |
© 2024 Biopharmanalyses - Powered by Samacom+